Methods and reporting studies assessing fecal microbiota transplantation a systematic review

Annals of Internal Medicine

Volumn 167, Issue 1, 2017, Pages 34-39

  Bafeta, Aïda ^a   Yavchitz, Amelie ^a   Riveros, Carolina ^a   Batista, Rui ^b   Ravaud, Philippe ^a  

^a PARIS DESCARTES UNIVERSITY   (France)

^b Service des Maladies Infectieuses et Tropicales Hôpitaux Universitaires Paris Nord Val   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIBLIOGRAPHIC DATABASE; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; DISEASE ASSOCIATION; FECAL MICROBIOTA TRANSPLANTATION; FUNDING; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; MEDICAL HISTORY; NONHUMAN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PUBLISHING; REVIEW; SIGMOIDOSCOPY; CLOSTRIDIUM INFECTIONS; INFLAMMATORY BOWEL DISEASES; METHODOLOGY; PEPTOCLOSTRIDIUM DIFFICILE;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FECAL MICROBIOTA TRANSPLANTATION; HUMANS; INFLAMMATORY BOWEL DISEASES; RESEARCH DESIGN;

EID: 85021822684     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M16-2810     Document Type: Review

References (50)

1. Aroniadis OC, Brandt LJ. Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol. 2013;29:79-84. [PMID: 23041678] doi:10.1097/MOG.0b013e32835a4b3e
2. Crow JR, Davis SL, Chaykosky DM, Smith TT, Smith JM. Probiotics and fecal microbiota transplant for primary and secondary prevention of Clostridium difficile infection. Pharmacotherapy. 2015;35:1016-25. [PMID: 26598094] doi:10.1002/phar.1644
3. Kelly CP, LaMont JT. Clostridium difficile-more difficult than ever. N Engl J Med. 2008;359:1932-40. [PMID: 18971494] doi:10.1056/NEJMra0707500
4. Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol. 2011;9:88-96. [PMID: 22183182] doi:10.1038/nrgastro.2011.244
5. Smits LP, Bouter KE, de Vos WM, Borody TJ, Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology. 2013;145:946-53. [PMID: 24018052] doi:10.1053/j.gastro.2013.08.058
6. Bakken JS, Borody T, Brandt LJ, Brill JV, Demarco DC, Franzos MA, et al; Fecal Microbiota Transplantation Workgroup. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2011;9:1044-9. [PMID: 21871249] doi: 10.1016/j.cgh.2011.08.014
7. Bowman KA, Broussard EK, Surawicz CM. Fecal microbiota transplantation: current clinical efficacy and future prospects. Clin Exp Gastroenterol. 2015;8:285-91. [PMID: 26566371] doi:10.2147/CEG. S61305
8. Nieuwdorp M. Faecal microbiota transplantation. Br J Surg. 2014;101:887-8. [PMID: 24844698] doi:10.1002/bjs.9549
9. Smith MB, Kelly C, Alm EJ. Policy: how to regulate faecal transplants. Nature. 2014;506:290-1. [PMID: 24558658]
10. Spector T, Knight R. Faecal transplants [Editorial]. BMJ. 2015;351:h5149. [PMID: 26487671] doi:10.1136/bmj.h5149
11. Vyas D, Aekka A, Vyas A. Fecal transplant policy and legislation. World J Gastroenterol. 2015;21:6-11. [PMID: 25574076] doi:10.3748/wjg.v21.i1.6
12. Weil AA, Hohmann EL. Fecal microbiota transplant: benefits and risks. Open Forum Infect Dis. 2015;2:ofv005. [PMID: 26034756] doi: 10.1093/ofid/ofv005
13. Surawicz CM. Fecal microbiota transplantation: what we know and what we need to know [Editorial]. Ann Intern Med. 2015;162:662-3. [PMID: 25938997] doi:10.7326/M15-0609
14. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011;53:994-1002. [PMID: 22002980] doi:10.1093/cid/cir632
15. Duff JM, Leather H, Walden EO, LaPlant KD, George TJ Jr. Adequacy of published oncology randomized controlled trials to provide therapeutic details needed for clinical application. J Natl Cancer Inst. 2010;102:702-5. [PMID: 20410466] doi:10.1093/jnci/djq117
16. Hoffmann TC, Erueti C, Glasziou PP. Poor description of nonpharmacological interventions: analysis of consecutive sample of randomised trials. BMJ. 2013;347:f3755. [PMID: 24021722] doi:10.1136/bmj.f3755
17. Jacquier I, Boutron I, Moher D, Roy C, Ravaud P. The reporting of randomized clinical trials using a surgical intervention is in need of immediate improvement: a systematic review. Ann Surg. 2006;244:677-83. [PMID: 17060758]
18. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151:W65-94. [PMID: 19622512]
19. Drekonja D, Reich J, Gezahegn S, Greer N, Shaukat A, MacDonald R, et al. Fecal microbiota transplantation for Clostridium difficile infection: a systematic review. Ann Intern Med. 2015;162:630-8. [PMID: 25938992] doi:10.7326/M14-2693
20. Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015;313:398-408. [PMID: 25626036] doi:10.1001/jama.2014.17103
21. Baxter M, Colville A. Adverse events in faecal microbiota transplant: a review of the literature. J Hosp Infect. 2016;92:117-27. [PMID: 26803556] doi:10.1016/j.jhin. 2015.10.024
22. Di Bella S, Gouliouris T, Petrosillo N. Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients. J Infect Chemother. 2015;21:230-7. [PMID: 25703532] doi:10.1016/j.jiac.2015.01.011
23. Ianiro G, Bibbò S, Scaldaferri F, Gasbarrini A, Cammarota G. Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitement. Medicine (Baltimore). 2014;93:e97. [PMID: 25340496] doi:10.1097/MD.0000000000000097
24. Scaldaferri F, Pecere S, Petito V, Zambrano D, Fiore L, Lopetuso LR, et al. Efficacy and mechanisms of action of fecal microbiota transplantation in ulcerative colitis: pitfalls and promises from a first metaanalysis. Transplant Proc. 2016;48:402-7. [PMID: 27109966] doi:10.1016/j.transproceed.2015.12.040
25. Li YT, Cai HF, Wang ZH, Xu J, Fang JY. Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection. Aliment Pharmacol Ther. 2016;43:445-57. [PMID: 26662643] doi:10.1111/apt.13492
26. Colman RJ, Rubin DT. Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and metaanalysis. J Crohns Colitis. 2014;8:1569-81. [PMID: 25223604] doi:10.1016/j.crohns.2014.08.006
27. Kelly CR, Kahn S, Kashyap P, Laine L, Rubin D, Atreja A, et al. Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology. 2015;149:223-37. [PMID: 25982290] doi:10.1053/j.gastro.2015.05.008
28. Shanahan F, Quigley EM. Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies. Gastroenterology. 2014;146:1554-63. [PMID: 24486051] doi:10.1053/j.gastro.2014.01.050
29. Petrof EO, Khoruts A. From stool transplants to next-generation microbiota therapeutics. Gastroenterology. 2014;146:1573-82. [PMID: 24412527] doi:10.1053/j.gastro.2014.01.004
30. Khoruts A, Weingarden AR. Emergence of fecal microbiota transplantation as an approach to repair disrupted microbial gut ecology. Immunol Lett. 2014;162:77-81. [PMID: 25106113] doi:10.1016/j.imlet.2014.07.016
31. Batista R, Kapel N, Megerlin F, Chaumeil JC, Barbut F, Bourlioux P, et al. [Fecal microbiota transplantation in recurrent Clostridium difficile infections. Framework and pharmaceutical preparation aspects]. Ann Pharm Fr. 2015;73:323-31. [PMID: 25825054] doi:10.1016/j.pharma.2015.02.004
32. Sokol H, Galperine T, Kapel N, Bourlioux P, Seksik P, Barbut F, et al; French Group of Faecal microbiota Transplantation (FGFT). Faecal microbiota transplantation in recurrent Clostridium difficile infection: recommendations from the French Group of Faecal microbiota Transplantation. Dig Liver Dis. 2016;48:242-7. [PMID: 26433619] doi:10.1016/j.dld.2015.08.017
33. Moossavi S, Bishehsari F, Ansari R, Vahedi H, Nasseri-Moghaddam S, Merat S, et al. Minimum requirements for reporting fecal microbiota transplant trial. Middle East J Dig Dis. 2015;7:177-80. [PMID: 26396721]
34. Owens C, Broussard E, Surawicz C. Fecal microbiota transplantation and donor standardization. Trends Microbiol. 2013;21:443-5. [PMID: 24012274] doi:10.1016/j.tim.2013.07.003
35. Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S, et al; MetaHIT consortium. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. 2015;528:262-6. [PMID: 26633628] doi:10.1038/nature 15766
36. Mullish BH, Williams HR. Obstacles to establishing an NHS faecal transplant programme [Letter]. BMJ. 2015;351:h6043. [PMID: 26585376] doi:10.1136/bmj.h6043
37. Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687. [PMID: 24609605] doi:10.1136/bmj.g1687
38. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P; CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148:295-309. [PMID: 18283207]
39. Ioannidis JP, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, et al. Increasing value and reducing waste in research design, conduct, and analysis. Lancet. 2014;383:166-75. [PMID: 24411645] doi:10.1016/S0140-6736 (13) 62227-8
40. Yordanov Y, Dechartres A, Porcher R, Boutron I, Altman DG, Ravaud P. Avoidable waste of research related to inadequate methods in clinical trials. BMJ. 2015;350:h809. [PMID: 25804210] doi:10.1136/bmj.h809
41. Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet. 2009;374:86-9. [PMID: 19525005] doi:10.1016/S0140-6736 (09) 60329-9
42. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M; Medical Research Council Guidance. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655. [PMID: 18824488] doi:10.1136/bmj.a1655
43. Dodin M, Katz DE. Faecal microbiota transplantation for Clostridium difficile infection. Int J Clin Pract. 2014;68:363-8. [PMID: 24372725] doi:10.1111/ijcp. 12320
44. Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and metaanalysis. AmJ Gastroenterol. 2013;108:500-8. [PMID: 23511459] doi: 10.1038/ajg.2013.59
45. Keshteli AH, Millan B, Madsen KL. Pretreatment with antibiotics may enhance the efficacy of fecal microbiota transplantation in ulcerative colitis: a meta-analysis. Mucosal Immunol. 2017;10:565-6. [PMID: 28000680] doi:10.1038/mi.2016.123
46. Rossen NG, MacDonald JK, de Vries EM, D'Haens GR, de Vos WM, Zoetendal EG, et al. Fecal microbiota transplantation as novel therapy in gastroenterology: a systematic review. World J Gastroenterol. 2015;21:5359-71. [PMID: 25954111] doi:10.3748/wjg.v21.i17.5359
47. Shi Y, Dong Y, Huang W, Zhu D, Mao H, Su P. Fecal microbiota transplantation for ulcerative colitis: a systematic review and metaanalysis. PLoS One. 2016;11:e0157259. [PMID: 27295210] doi:10.1371/journal.pone.0157259
48. Sofi AA, Silverman AL, Khuder S, Garborg K, Westerink JM, Nawras A. Relationship of symptom duration and fecal bacteriotherapy in Clostridium difficile infection-pooled data analysis and a systematic review. Scand J Gastroenterol. 2013;48:266-73. [PMID: 23163886] doi:10.3109/00365521.2012.743585
49. Sun D, Li W, Li S, Cen Y, Xu Q, Li Y, et al. Fecal microbiota transplantation as a novel therapy for ulcerative colitis: a systematic review and meta-analysis. Medicine (Baltimore). 2016;95:e3765. [PMID: 27281075] doi:10.1097/MD.0000000000003765
50. Vale CL, Tierney JF, Burdett S. Can trial quality be reliably assessed from published reports of cancer trials: evaluation of risk of bias assessments in systematic reviews. BMJ. 2013;346:f1798. [PMID: 23610376] doi:10.1136/bmj.f1798